Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.
Br J Haematol
; 200(6): 717-721, 2023 03.
Article
de En
| MEDLINE
| ID: mdl-36442510
ABSTRACT
Data for COVID-19 vaccine response in patients with immune thrombocytopenia (ITP) are very limited. In a study of 28 patients with ITP, anti-severe acute respiratory syndrome coronavirus 2 spike antibody titres were measured after vaccination. The seroconversion rate for ITP patients was 91.3%, comparable to that in healthy controls (HCs). However, the antibody titre in ITP patients was significantly lower than that in HCs and declined with ageing. Furthermore, the antibody titre in ITP patients who received a minimum prednisolone dose of at least 5 mg/day at any time-point at or after initial vaccination was lower than that in other patients.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Thrombopénie
/
Purpura thrombopénique idiopathique
/
COVID-19
Limites:
Humans
Langue:
En
Journal:
Br J Haematol
Année:
2023
Type de document:
Article
Pays d'affiliation:
Japon